Researchers identify women with twice the risk of cancer in both breasts

by Mayo ClinicCumulative incidence of CBC risk in PV carriers. Cumulative incidence plots for first contralateral breast cancers after primary breast cancer. Cumulative incidence is plotted again

Updated on: February 18,2024

Researchers identify women with twice the risk of cancer in both breasts

by Mayo ClinicCumulative incidence of CBC risk in PV carriers. Cumulative incidence plots for first contralateral breast cancers after primary breast cancer. Cumulative incidence is plotted again

Updated on:February 18,2024

Biomarkers show promise for identifying early risk of pancreatic cancer

byDuke University Medical CenterCredit: Pixabay/CC0 Public DomainA research team at Duke Health has identified a set of biomarkers that could help distinguish whether cysts on the pancreas are l

Updated on: January 04,2024

Biomarkers show promise for identifying early risk of pancreatic cancer

byDuke University Medical CenterCredit: Pixabay/CC0 Public DomainA research team at Duke Health has identified a set of biomarkers that could help distinguish whether cysts on the pancreas are l

Updated on:January 04,2024

'Synthetic immune niche' approach enhances T-cell proliferation without compromising cancer-killing ability

byWeizmann Institute of ScienceComparison of the significant differences in gene expression profiles between DC-activated cells (orange dots) and bead-activated cells (black dots) on their '

Updated on: September 28,2024

'Synthetic immune niche' approach enhances T-cell proliferation without compromising cancer-killing ability

byWeizmann Institute of ScienceComparison of the significant differences in gene expression profiles between DC-activated cells (orange dots) and bead-activated cells (black dots) on their '

Updated on:September 28,2024

Major progress in curing brain tumors by blocking certain functions in cells with a docked molecule

by University of GothenburgThe researchers’ molecule Z4P inhibits one of the mechanisms that regulate protein production in a cancer cell. This inhibition causes the cancer cell to die. Three pic

Updated on: February 18,2024

Major progress in curing brain tumors by blocking certain functions in cells with a docked molecule

by University of GothenburgThe researchers’ molecule Z4P inhibits one of the mechanisms that regulate protein production in a cancer cell. This inhibition causes the cancer cell to die. Three pic

Updated on:February 18,2024

New gene implicated in cancer, cellular stress response

by Olivia Dimmer,Northwestern UniversityTissue-restricted expression of mammalian HAPSTR2. a Transcript abundance of HAPSTR1 and HAPSTR2 in the indicated human tissues; GTEx RNA-seq data. TPM, t

Updated on: February 18,2024

New gene implicated in cancer, cellular stress response

by Olivia Dimmer,Northwestern UniversityTissue-restricted expression of mammalian HAPSTR2. a Transcript abundance of HAPSTR1 and HAPSTR2 in the indicated human tissues; GTEx RNA-seq data. TPM, t

Updated on:February 18,2024

Researchers make major advance with cancer-killing antibody-drug conjugates

by Doug Bennett,University of FloridaCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01771Building a new precision cancer treatment comes with no shortage of

Updated on: February 20,2024

Researchers make major advance with cancer-killing antibody-drug conjugates

by Doug Bennett,University of FloridaCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01771Building a new precision cancer treatment comes with no shortage of

Updated on:February 20,2024

Researchers show liquid biopsies can catch disease progression early in high-risk neuroblastoma

by Children's Hospital of PhiladelphiaCredit: Unsplash/CC0 Public DomainNeuroblastoma is an aggressive pediatric cancer that develops from early nerve cells and accounts for up to 10% of chil

Updated on: February 18,2024

Researchers show liquid biopsies can catch disease progression early in high-risk neuroblastoma

by Children's Hospital of PhiladelphiaCredit: Unsplash/CC0 Public DomainNeuroblastoma is an aggressive pediatric cancer that develops from early nerve cells and accounts for up to 10% of chil

Updated on:February 18,2024

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the

Updated on: January 29,2024

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the

Updated on:January 29,2024

Triple-drug therapy for post-transplant management of multiple myeloma

by University of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainResearchers from the University of Chicago Medicine Comprehensive Cancer Center and colleagues in Poland report promising

Updated on: February 18,2024

Triple-drug therapy for post-transplant management of multiple myeloma

by University of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainResearchers from the University of Chicago Medicine Comprehensive Cancer Center and colleagues in Poland report promising

Updated on:February 18,2024

New machine learning model improves prediction of prostate cancer recurrence

byElsevierCredit: Pixabay/CC0 Public DomainPredicting the course of prostate cancer is challenging because only a fraction of prostate cancer patients experience recurrence after radical prostat

Updated on: January 11,2024

New machine learning model improves prediction of prostate cancer recurrence

byElsevierCredit: Pixabay/CC0 Public DomainPredicting the course of prostate cancer is challenging because only a fraction of prostate cancer patients experience recurrence after radical prostat

Updated on:January 11,2024

Gut bacteria engineered to act as tumor GPS for immunotherapies

byDana-Farber Cancer InstituteBacteria displaying hDR18 enhance anti-tumor responses of MSLN-CAR NK cells. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-024-02418-6Immunothe

Updated on: October 10,2024

Gut bacteria engineered to act as tumor GPS for immunotherapies

byDana-Farber Cancer InstituteBacteria displaying hDR18 enhance anti-tumor responses of MSLN-CAR NK cells. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-024-02418-6Immunothe

Updated on:October 10,2024

Researchers pinpoint why lymphoma patients may become resistant to specific therapy

by H. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0With more targeted

Updated on: June 01,2024

Researchers pinpoint why lymphoma patients may become resistant to specific therapy

by H. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0With more targeted

Updated on:June 01,2024